APP and early-onset autosomal dominant Alzheimer disease: (115) demonstrated that HHT alleviates neuroinflammation in amyloid precursor protein/presenilin 1 (APP/PS1) mice by disrupting the STAT3 pathway, thereby slowing the progression of Alzheimer’s disease.